# Allotrope Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/allotrope-medical

- Industry: Medical Devices & Equipment
- Headquarters: Houston, US
- Website: www.allotropemed.com
- Total disclosed funding: $4M
- Latest round: Series A (Jun 1, 2021)
- Investors on record: 10

## About

Allotrope Medical Inc., based in Houston, US, focuses on enhancing the surgical experience for doctors and patients through innovative medical solutions. Their approach centers on developing advanced technologies that aim to improve surgical outcomes.Established in 2016 and headquartered in Houston, US, Allotrope Medical Inc. specializes in medical innovation to improve surgical procedures. The company has raised a total of USD 4.00 mn through various funding rounds, with its latest being a Series A round in June 2021, led by Rockies Venture Fund. Albert Huang is both the founder and the CEO of the company, providing leadership with a background that includes prior entrepreneurial experience. Allotrope Medical Inc. has closed five deals to date, focusing on enhancing their market presence.Allotrope Medical Inc. develops specialized medical technologies aimed at improving surgical procedures. Their product offerings include unique devices designed to optimize surgical workflows and enhance patient recovery. The company primarily serves healthcare providers in the United States, aiming to deliver innovative solutions that cater to a range of surgical applications.Allotrope Medical Inc. operates on a revenue model primarily based on the sales of its specialized medical devices. The company has established a foundation for revenue generation through its innovative product line, targeting hospitals and surgical centers that seek improvements in surgical efficiency and patient outcomes.In June 2021, Allotrope Medical Inc. raised USD 4.00 mn in Series A funding, led by Rockies Venture Fund, to accelerate its commercialization plans. The company aims to enhance the surgical experience by advancing its product lineup and improving distribution channels across the US. Upcoming products are in development, with a focus on expanding their reach in new geographic markets, including targeted regions in North America by the end of 2023. This funding will facilitate the company's strategic initiatives, ensuring they meet the evolving needs of healthcare providers.

## Funding rounds

- Series A, Jun 1, 2021, $4M — Tech Coast Angels, Bellingham Angel Investors, Rockies Venture Fund, Berkeley Angel Network, Texas Halo Fund, MEDA Angels, SeedFolio, Aggie Angel Network, Kentucky Select Fund, Prosalus Capital Partners

## Investors

- Tech Coast Angels — Series A
- Bellingham Angel Investors (https://capitalatlas.ai/funds/bellingham-angel-investors) — Series A
- Rockies Venture Fund (https://capitalatlas.ai/funds/rockies-venture-fund) — Series A
- Berkeley Angel Network — Series A
- Texas Halo Fund (https://capitalatlas.ai/funds/texas-halo-fund) — Series A
- MEDA Angels (https://capitalatlas.ai/funds/meda-angels) — Series A
- SeedFolio (https://capitalatlas.ai/funds/seedfolio) — Series A
- Aggie Angel Network (https://capitalatlas.ai/funds/aggie-angel-network) — Series A
- Kentucky Select Fund (https://capitalatlas.ai/funds/kentucky-select-fund) — Series A
- Prosalus Capital Partners (https://capitalatlas.ai/funds/prosalus-capital-partners) — Series A